| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |